Predicting disease progression in alzheimer's disease: The role of neuropsychiatric syndromes on functional and cognitive decline

Katie Palmer, Federica Lupo, Roberta Perri, Giovanna Salamone, Lucia Fadda, Carlo Caltagirone, Massimo Musicco, Luca Cravello

Research output: Contribution to journalArticle

Abstract

Patients with Alzheimer's disease (AD) have heterogeneous rates of disease progression. The aim of the current study is to investigate whether neuropsychiatric disturbances predict cognitive and functional disease progression in AD, according to failure theory. We longitudinally examined 177 memory-clinic AD outpatients (mean age = 73.1, SD = 8.1; 70.6% women). Neuropsychiatric disturbances at baseline were categorized into five syndromes. Patients were followed for up to two years to detect rapid disease progression defined as a loss of ≥ 1 abilities in Activities of Daily living (ADL) or a drop of ≥ 5 points on Mini-Mental State Examination (MMSE). Hazard ratios (HR) were calculated with Gompertz regression, adjusting for sociodemographics, baseline cognitive and functional status, and somatic comorbidities. Most patients (74.6%) exhibited one or more neuropsychiatric syndromes at baseline. The most common neuropsychiatric syndrome was Apathy (63.8%), followed by Affective (37.3%), Psychomotor (8.5%), Manic (7.9%), and Psychotic (5.6%) syndromes. The variance between the observed (Kaplen Meier) and predicted (Gompertz) decline for disease progression in cognition (0.30, CI = 0.26-0.35), was higher than the variance seen for functional decline (0.22, CI = 0.18-0.26). After multiple adjustment, patients with the Affective syndrome had an increased risk of functional decline (HR = 2.0; CI = 1.1-3.6), whereas the risk of cognitive decline was associated with the Manic (HR = 3.2, CI = 1.3-7.5) syndrome. In conclusion, specific neuropsychiatric syndromes are associated with functional and cognitive decline during the progression of AD, which may help with the long-term planning of care and treatment. These results highlight the importance of incorporating a thorough psychiatric examination in the evaluation of AD patients.

Original languageEnglish
Pages (from-to)35-45
Number of pages11
JournalJournal of Alzheimer's Disease
Volume24
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Disease Progression
Alzheimer Disease
Social Adjustment
Apathy
Aptitude
Long-Term Care
Activities of Daily Living
Cognitive Dysfunction
Cognition
Psychiatry
Comorbidity
Outpatients

Keywords

  • Activities of daily living
  • anxiety
  • apathy
  • behavioral and psychological symptoms of dementia
  • cognitive impairment
  • dementia
  • depression
  • disease progression
  • failure theory
  • Gompertz

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Predicting disease progression in alzheimer's disease : The role of neuropsychiatric syndromes on functional and cognitive decline. / Palmer, Katie; Lupo, Federica; Perri, Roberta; Salamone, Giovanna; Fadda, Lucia; Caltagirone, Carlo; Musicco, Massimo; Cravello, Luca.

In: Journal of Alzheimer's Disease, Vol. 24, No. 1, 2011, p. 35-45.

Research output: Contribution to journalArticle

@article{bea98f572a634e55ab6f7a8ee1451402,
title = "Predicting disease progression in alzheimer's disease: The role of neuropsychiatric syndromes on functional and cognitive decline",
abstract = "Patients with Alzheimer's disease (AD) have heterogeneous rates of disease progression. The aim of the current study is to investigate whether neuropsychiatric disturbances predict cognitive and functional disease progression in AD, according to failure theory. We longitudinally examined 177 memory-clinic AD outpatients (mean age = 73.1, SD = 8.1; 70.6{\%} women). Neuropsychiatric disturbances at baseline were categorized into five syndromes. Patients were followed for up to two years to detect rapid disease progression defined as a loss of ≥ 1 abilities in Activities of Daily living (ADL) or a drop of ≥ 5 points on Mini-Mental State Examination (MMSE). Hazard ratios (HR) were calculated with Gompertz regression, adjusting for sociodemographics, baseline cognitive and functional status, and somatic comorbidities. Most patients (74.6{\%}) exhibited one or more neuropsychiatric syndromes at baseline. The most common neuropsychiatric syndrome was Apathy (63.8{\%}), followed by Affective (37.3{\%}), Psychomotor (8.5{\%}), Manic (7.9{\%}), and Psychotic (5.6{\%}) syndromes. The variance between the observed (Kaplen Meier) and predicted (Gompertz) decline for disease progression in cognition (0.30, CI = 0.26-0.35), was higher than the variance seen for functional decline (0.22, CI = 0.18-0.26). After multiple adjustment, patients with the Affective syndrome had an increased risk of functional decline (HR = 2.0; CI = 1.1-3.6), whereas the risk of cognitive decline was associated with the Manic (HR = 3.2, CI = 1.3-7.5) syndrome. In conclusion, specific neuropsychiatric syndromes are associated with functional and cognitive decline during the progression of AD, which may help with the long-term planning of care and treatment. These results highlight the importance of incorporating a thorough psychiatric examination in the evaluation of AD patients.",
keywords = "Activities of daily living, anxiety, apathy, behavioral and psychological symptoms of dementia, cognitive impairment, dementia, depression, disease progression, failure theory, Gompertz",
author = "Katie Palmer and Federica Lupo and Roberta Perri and Giovanna Salamone and Lucia Fadda and Carlo Caltagirone and Massimo Musicco and Luca Cravello",
year = "2011",
doi = "10.3233/JAD-2010-101836",
language = "English",
volume = "24",
pages = "35--45",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Predicting disease progression in alzheimer's disease

T2 - The role of neuropsychiatric syndromes on functional and cognitive decline

AU - Palmer, Katie

AU - Lupo, Federica

AU - Perri, Roberta

AU - Salamone, Giovanna

AU - Fadda, Lucia

AU - Caltagirone, Carlo

AU - Musicco, Massimo

AU - Cravello, Luca

PY - 2011

Y1 - 2011

N2 - Patients with Alzheimer's disease (AD) have heterogeneous rates of disease progression. The aim of the current study is to investigate whether neuropsychiatric disturbances predict cognitive and functional disease progression in AD, according to failure theory. We longitudinally examined 177 memory-clinic AD outpatients (mean age = 73.1, SD = 8.1; 70.6% women). Neuropsychiatric disturbances at baseline were categorized into five syndromes. Patients were followed for up to two years to detect rapid disease progression defined as a loss of ≥ 1 abilities in Activities of Daily living (ADL) or a drop of ≥ 5 points on Mini-Mental State Examination (MMSE). Hazard ratios (HR) were calculated with Gompertz regression, adjusting for sociodemographics, baseline cognitive and functional status, and somatic comorbidities. Most patients (74.6%) exhibited one or more neuropsychiatric syndromes at baseline. The most common neuropsychiatric syndrome was Apathy (63.8%), followed by Affective (37.3%), Psychomotor (8.5%), Manic (7.9%), and Psychotic (5.6%) syndromes. The variance between the observed (Kaplen Meier) and predicted (Gompertz) decline for disease progression in cognition (0.30, CI = 0.26-0.35), was higher than the variance seen for functional decline (0.22, CI = 0.18-0.26). After multiple adjustment, patients with the Affective syndrome had an increased risk of functional decline (HR = 2.0; CI = 1.1-3.6), whereas the risk of cognitive decline was associated with the Manic (HR = 3.2, CI = 1.3-7.5) syndrome. In conclusion, specific neuropsychiatric syndromes are associated with functional and cognitive decline during the progression of AD, which may help with the long-term planning of care and treatment. These results highlight the importance of incorporating a thorough psychiatric examination in the evaluation of AD patients.

AB - Patients with Alzheimer's disease (AD) have heterogeneous rates of disease progression. The aim of the current study is to investigate whether neuropsychiatric disturbances predict cognitive and functional disease progression in AD, according to failure theory. We longitudinally examined 177 memory-clinic AD outpatients (mean age = 73.1, SD = 8.1; 70.6% women). Neuropsychiatric disturbances at baseline were categorized into five syndromes. Patients were followed for up to two years to detect rapid disease progression defined as a loss of ≥ 1 abilities in Activities of Daily living (ADL) or a drop of ≥ 5 points on Mini-Mental State Examination (MMSE). Hazard ratios (HR) were calculated with Gompertz regression, adjusting for sociodemographics, baseline cognitive and functional status, and somatic comorbidities. Most patients (74.6%) exhibited one or more neuropsychiatric syndromes at baseline. The most common neuropsychiatric syndrome was Apathy (63.8%), followed by Affective (37.3%), Psychomotor (8.5%), Manic (7.9%), and Psychotic (5.6%) syndromes. The variance between the observed (Kaplen Meier) and predicted (Gompertz) decline for disease progression in cognition (0.30, CI = 0.26-0.35), was higher than the variance seen for functional decline (0.22, CI = 0.18-0.26). After multiple adjustment, patients with the Affective syndrome had an increased risk of functional decline (HR = 2.0; CI = 1.1-3.6), whereas the risk of cognitive decline was associated with the Manic (HR = 3.2, CI = 1.3-7.5) syndrome. In conclusion, specific neuropsychiatric syndromes are associated with functional and cognitive decline during the progression of AD, which may help with the long-term planning of care and treatment. These results highlight the importance of incorporating a thorough psychiatric examination in the evaluation of AD patients.

KW - Activities of daily living

KW - anxiety

KW - apathy

KW - behavioral and psychological symptoms of dementia

KW - cognitive impairment

KW - dementia

KW - depression

KW - disease progression

KW - failure theory

KW - Gompertz

UR - http://www.scopus.com/inward/record.url?scp=79955668949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955668949&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-101836

DO - 10.3233/JAD-2010-101836

M3 - Article

C2 - 21157019

AN - SCOPUS:79955668949

VL - 24

SP - 35

EP - 45

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -